Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib

dbGaP Study Accession: phs002705.v1.p1

Study
phs002705.v1.p1

Variable Name and Accession: Variable Name: SUBJECT_ID
Variable Accession: phv00495855.v1.p1
Variable belongs to dataset: pht011839.v1.p1 : CLL_Reversal_Ibrutinib_Subject: This subject consent data table contains subject IDs, consent information, and subject's biological sex.
Variable Description: Subject ID
Statistical Summary